JPH01289491A - S-632-b1 and s-632-b2 substance - Google Patents
S-632-b1 and s-632-b2 substanceInfo
- Publication number
- JPH01289491A JPH01289491A JP63118873A JP11887388A JPH01289491A JP H01289491 A JPH01289491 A JP H01289491A JP 63118873 A JP63118873 A JP 63118873A JP 11887388 A JP11887388 A JP 11887388A JP H01289491 A JPH01289491 A JP H01289491A
- Authority
- JP
- Japan
- Prior art keywords
- chloroform
- chart
- substance
- reaction
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims description 44
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000002378 acidificating effect Effects 0.000 claims abstract description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000011630 iodine Substances 0.000 claims abstract description 6
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 6
- 230000007935 neutral effect Effects 0.000 claims abstract description 6
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims abstract description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 34
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000000862 absorption spectrum Methods 0.000 claims description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 claims description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims description 6
- 238000000921 elemental analysis Methods 0.000 claims description 4
- 238000004949 mass spectrometry Methods 0.000 claims description 4
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 claims description 4
- -1 Ehrlich Chemical compound 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 9
- 241000187747 Streptomyces Species 0.000 abstract description 6
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 241000233866 Fungi Species 0.000 abstract description 3
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 238000001819 mass spectrum Methods 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 6
- 108010080698 Peptones Proteins 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 235000019319 peptone Nutrition 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000187180 Streptomyces sp. Species 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012156 elution solvent Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 101000852665 Alopecosa marikovskyi Omega-lycotoxin-Gsp2671a Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000012474 bioautography Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000000445 cytocidal effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229910001385 heavy metal Chemical class 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、抗生物質等として有用な新規な物質に関する
。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a novel substance useful as an antibiotic or the like.
従来の技術及びその課題
本発明の8 632 B+およびS−632−B2物
質は、文献未記載の新規化合物である。Prior Art and its Problems The 8 632 B+ and S-632-B2 substances of the present invention are novel compounds that have not been described in any literature.
本発明の目的は、抗生物質等として有用な一ヒ記新規物
質を提供することにある。An object of the present invention is to provide a novel substance useful as an antibiotic or the like.
課題を解決するための手段
上記目的は、下記性質を有するS−632−B、および
S−632−B2物質により達成される。Means for Solving the Problems The above objects are achieved by S-632-B and S-632-B2 substances having the following properties.
(S−632B+物質〕 (1) 性状:淡黄色油状物質。(S-632B+substance) (1) Properties: Pale yellow oily substance.
(2)分子量:323(電子衝撃(EI)マススペクト
ル法による)。(2) Molecular weight: 323 (according to electron impact (EI) mass spectroscopy).
(3)元素分析値(%):C62,76、H7,71、
N4.12゜
(4)比旋光度: 〔α〕菅=+68° (C=1.0
)クロロホルム中)。(3) Elemental analysis value (%): C62,76, H7,71,
N4.12° (4) Specific rotation: [α] Suga = +68° (C = 1.0
) in chloroform).
(5) 紫外吸収スペクトル:エタノール中、λma
x (止)(ε):206 (14500)、282
(450)。チャートを第1図に示す。(5) Ultraviolet absorption spectrum: in ethanol, λma
x (stop) (ε): 206 (14500), 282
(450). The chart is shown in Figure 1.
(6)赤外吸収スペクトル:液膜法(クロロホルム中)
、νmax (cm1): 3490.2915.1
710.1697.1370.1245゜チャートを第
3図に示す。(6) Infrared absorption spectrum: liquid film method (in chloroform)
, νmax (cm1): 3490.2915.1
710.1697.1370.1245° chart is shown in Figure 3.
(7)核磁気共鳴スペクトル二重クロロホルム中、10
0M)(zで測定したチャートを第5図に示す。(7) Nuclear magnetic resonance spectrum in double chloroform, 10
A chart measured at 0M) (z is shown in FIG. 5).
(8)溶解性:メタノール、エタノール、クロロホルム
、アセトン、酢酸エチル、ジメチルスルホキシドに良く
溶け、ヘキサン、エーテルにわずかに溶け、水に不溶で
ある。(8) Solubility: Well soluble in methanol, ethanol, chloroform, acetone, ethyl acetate, and dimethyl sulfoxide, slightly soluble in hexane and ether, and insoluble in water.
(9) 呈色反応:ヨード蒸気、硫酸、エーリッヒ、
リンモリブデン酸反応に陽性。ニンヒドリン、トレンス
反応に陰性。(9) Color reaction: iodine vapor, sulfuric acid, Ehrlich,
Positive for phosphomolybdic acid reaction. Negative for ninhydrin and Tollens reaction.
<II塩基性、酸性、中性の区別二弱酸性。<II Distinction between basic, acidic, and neutral Weakly acidic.
(S−632−82物質〕 (1)性状:淡黄色油状物質。(S-632-82 substance) (1) Properties: Pale yellow oily substance.
(2)分子量:323(電子衝撃(EI)マススペクト
ル法による)。(2) Molecular weight: 323 (according to electron impact (EI) mass spectroscopy).
(3)元素分析値(%):C62,59、H7,91、
N4.23゜
(4)比旋光度: 〔α〕合=+73° (C=1.0
)クロロホルム中)。(3) Elemental analysis value (%): C62,59, H7,91,
N4.23° (4) Specific rotation: [α] = +73° (C = 1.0
) in chloroform).
(5)紫外吸収スペクトル:エタノール中、λmax
(nm)(ε): 207 (14800)、280
(610)。チャートを第2図に示す。(5) Ultraviolet absorption spectrum: in ethanol, λmax
(nm) (ε): 207 (14800), 280
(610). The chart is shown in Figure 2.
(6) 赤外吸収スペクトル:液膜法(クロロホルム
中)、νwax (cm”):3350)2920.
1725.1705.1250゜チャートを第4図に示
す。(6) Infrared absorption spectrum: liquid film method (in chloroform), νwax (cm”): 3350) 2920.
The 1725.1705.1250° chart is shown in Figure 4.
(7)核磁気共鳴スペクトル:重クロロホルム中、10
0MHzで測定したチャートを第6図に示す。(7) Nuclear magnetic resonance spectrum: in deuterated chloroform, 10
A chart measured at 0 MHz is shown in FIG.
(8)溶解性:メタノール、エタノール、クロロホルム
、アセトン、酢酸エチル、ジメチルスルホキシドに良く
溶け、ヘキサン、エーテルにわずかに溶け、水に不溶で
ある。(8) Solubility: Well soluble in methanol, ethanol, chloroform, acetone, ethyl acetate, and dimethyl sulfoxide, slightly soluble in hexane and ether, and insoluble in water.
(9)呈色反応:ヨード蒸気、硫酸、エーリッヒ、リン
モリブデン酸反応に陽性。ニンヒドリン、トレンス反応
に陰性。(9) Color reaction: Positive for iodine vapor, sulfuric acid, Ehrlich, and phosphomolybdic acid reactions. Negative for ninhydrin and Tollens reaction.
(101塩基性、酸性、中性の区別:弱酸性。(101 Distinction between basic, acidic, and neutral: weak acidity.
本発明のS−632B+およびS−632−82物質は
、サツ力ロフイセス(S accharomyces)
属の酵母類等の真菌類等に抗菌活性を有する。The S-632B+ and S-632-82 substances of the present invention are derived from Saccharomyces.
It has antibacterial activity against fungi such as yeasts of the genus.
また、S−632B+およびS−632−B2物質は、
ヒト鼻咽腔癌由来の株化培養細胞(KB細胞)に対する
殺細胞作用をも有する。In addition, S-632B+ and S-632-B2 substances are
It also has a cytocidal effect on cultured cell lines (KB cells) derived from human nasopharyngeal carcinoma.
本発明のS−632B+およびS−632−82物質は
、微生物の培養により得ることができる。即ち、本物質
はS−632−B、およびS−632−B2物質の生産
能力を有する菌株(以下S−632物質生産菌と称する
。)を適当な条件下で培養することによって培養液がら
採取することができる。The S-632B+ and S-632-82 substances of the present invention can be obtained by culturing microorganisms. That is, this substance can be obtained by culturing S-632-B and a strain capable of producing S-632-B2 substance (hereinafter referred to as S-632 substance-producing bacteria) under appropriate conditions, and then collecting the culture fluid. can do.
本物質の製造に用い得るS−632物質生産菌には、ス
トレプトミセス(S treptomyces )属に
属する菌株が包含される。その−例として、ストレプト
ミセス・スピーシーズS−632(S trcptom
yccs 5pecies S −632)株を例示で
きる。この菌株は、本発明者らが中華人民共和国山東省
の土壌から新たに分離したストレプトミセス属に属する
菌株であり、通商産業省工業技術院微生物工業技術研究
所に、微生物の表示rstrain S−632J 、
受託番号[微工研条寄第1849号(FERM BP
−1849)Jとして寄託されている。S-632 substance-producing bacteria that can be used to produce the present substance include strains belonging to the genus Streptomyces. As an example, Streptomyces sp. S-632 (S trcptom
yccs 5pecies S-632) strain. This strain belongs to the genus Streptomyces, which the present inventors newly isolated from soil in Shandong Province, People's Republic of China. ,
Accession number [FERM BP No. 1849 (FERM BP)
-1849) has been deposited as J.
その菌学的性質は、次の通りである。Its mycological properties are as follows.
(a)形態 胞子形成菌糸の分枝法:単純分枝。(a) Form Branching method of spore-forming hyphae: simple branching.
胞子形成の形態:螺旋状(spirals ) (胞
子の形は円筒状)。Morphology of sporulation: spirals (spore shape is cylindrical).
胞子の数:10〜50胞子又はそれ以上。Number of spores: 10-50 spores or more.
胞子の表面構造:著しいしわ状(rugose)、輪郭
はこぶ状(warty ) 、一部平滑(smooth
) 。Spore surface structure: markedly wrinkled, warty, partially smooth
).
胞子の大きさ:0.8〜1.0X1.1〜1.2μm(
ただし個々の胞子形が不明瞭のものが多い)。Spore size: 0.8~1.0X1.1~1.2μm (
However, in many cases the individual spore shapes are unclear).
鞭毛胞子の有無:無。Presence or absence of flagellated spores: None.
胞子のうの有無:無。Presence or absence of sporangia: None.
胞子柄の着生位置:気菌糸。Spore stalk epiphyte position: aerial hyphae.
菌核形成性の有無:無。Presence or absence of sclerotia formation: None.
(b)各種培地における生育状態 各種培地における生育状態は第1表に示す通りである。(b) Growth status in various media Growth conditions in various media are shown in Table 1.
観察法はISPの方法便覧に従い、分類色名は「色の標
準」 (日本色彩研究所)で示した。なお、詳細な色は
「カラー・ハーモニイ・マニュアル」の色コードで()
内にっけ加えた。The observation method was in accordance with the ISP method manual, and the classification color names were shown as "Color Standards" (Japan Color Research Institute). For detailed colors, please refer to the color code of "Color Harmony Manual" ()
I added it inside.
(c)生理的性質
生育温度範囲:27〜30℃の温度範囲で良好に生育す
る。(c) Physiological properties Growth temperature range: Grows well in a temperature range of 27 to 30°C.
ゼラチンの液化(グルコース・ペプトンφゼラチン培地
、27℃):陽性(弱い)。Liquefaction of gelatin (glucose/peptone φ gelatin medium, 27°C): Positive (weak).
同(単純ゼラチン培地、20℃):陰性。Same (simple gelatin medium, 20°C): Negative.
ミルクの凝固(37℃):陽性。Milk coagulation (37°C): Positive.
ミルクのペプトン化(37℃):陽性。Peptonization of milk (37°C): Positive.
メラニン様色素の生成:
チロシン寒天(ISP−7)培地上、ペプトン・酵母エ
キス・鉄寒天(ISP−6)培地上およびトリプトン・
酵母エキス(lSP−1)液体培地中で陰性。Production of melanin-like pigment: on tyrosine agar (ISP-7) medium, on peptone/yeast extract/iron agar (ISP-6) medium, and on tryptone/yeast extract/iron agar (ISP-6) medium.
Negative in yeast extract (lSP-1) liquid medium.
硫化水素の産生(ペプトン・酵母エキス・鉄寒天(IS
P−6)に0.5%酵母エキスを添加した培地):陽性
。Production of hydrogen sulfide (peptone, yeast extract, iron agar (IS)
P-6) with 0.5% yeast extract added): Positive.
デンプンの加水分解(スターチ・無機塩寒天、l5P−
4培地):陽性。Hydrolysis of starch (starch/inorganic salt agar, l5P-
4 medium): Positive.
硝酸塩の還元(1%硝酸カリウム含有ブイヨン、l5P
−8培地):陽性。Nitrate reduction (bouillon containing 1% potassium nitrate, l5P
-8 medium): Positive.
セルロースの分解:陰性。Cellulose degradation: negative.
(d)炭素源の利用性(ブリードハム・ゴトリーブ寒天
、l5P−9培地)
L−アラビノース、D−キシロース、D−7ラクトース
、シュークロース、L−ラムノース、ラフィノース、イ
ノシトール、D−マンニトール、D−ガラクトース、溶
性デンプン、デキストリン、グリセロールおよびマルト
ースを利用してよく発育し、D−グルコース、サリシン
を利用する。炭素源無添加の培地上でもわずかな生育が
認められる。(d) Availability of carbon sources (Breedham-Gotlieb agar, 15P-9 medium) L-arabinose, D-xylose, D-7 lactose, sucrose, L-rhamnose, raffinose, inositol, D-mannitol, D- It thrives on galactose, soluble starch, dextrin, glycerol and maltose, and utilizes D-glucose and salicin. Slight growth is observed even on a medium without carbon source addition.
(e)菌体組成
ベラカー(Becker)らの方法〔アプライド会ミク
ロバイオロジー(Appl、Microblol、 )
12.421〜423 (1964))により分析した
結果、LL型のジアミノピメリン酸が検出された。(e) Bacterial cell composition The method of Becker et al. [Appl, Microbiol, Inc.]
12.421-423 (1964)), LL type diaminopimelic acid was detected.
以上の菌学的性質、特に本菌株が基生菌糸より多数の胞
子の連鎖を有する気菌糸を形成し、細胞壁組成のアミノ
酸がLL−ジアミノピメリン酸であり、鞭毛胞子や胞子
のうを形成しない性質を有することから、ストレプトミ
セス属に属する菌株であることが明らかである。The above mycological properties, especially the characteristics that this strain forms aerial hyphae with more chains of spores than basal hyphae, that the amino acid in the cell wall composition is LL-diaminopimelic acid, and that it does not form flagellar spores or sporangia. It is clear that the strain belongs to the genus Streptomyces.
よって本菌株を、ストレプトミセス・スピーシーズS
−632(Streptomyces 5pecies
S −632)と称することとした。Therefore, this strain can be classified as Streptomyces sp.
-632 (Streptomyces 5pecies
S-632).
本発明のS −632−B +およびS−632−B2
物質は、例えば上記S−632株又はその変異株等のス
トレプトミセス属に属する各種のS−632物質生産菌
を適当な培地で培養することにより製造できる。S-632-B+ and S-632-B2 of the present invention
The substance can be produced by culturing various S-632 substance-producing bacteria belonging to the genus Streptomyces, such as the above-mentioned S-632 strain or its mutant strains, in an appropriate medium.
上記微生物の培養は、原則的に一般微生物の培養に準じ
るものであり、通常液体培養による振盪培養法、通気撹
拌培養法等の好気的条件下で行なわれるのが好適である
。The cultivation of the above-mentioned microorganisms is in principle similar to the cultivation of general microorganisms, and is preferably carried out under aerobic conditions, such as a shaking culture method using liquid culture or an aerated agitation culture method.
培養に用いられる培地としては、S−632物質生産菌
が利用できる栄養源を含有する培地であればよく、各種
の合成培地、半合成培地、天然培地等をいずれも用いる
ことができる。培地組成としては炭素源としてのグルコ
ース、シュークロース、フラクトース、グリセリン、デ
キストリン、澱粉、糖蜜、コーン・ステイープ・リカー
、有機酸等を単独又は組合せて用い得る。窒素源として
はファーマメディア、ペプトン、肉エキス、酵母エキス
、大豆粉、カゼイン、アミノ酸、尿素等の有機窒素源、
硝酸ナトリウム、硫酸アンモニウム等の無機窒素源を単
独又は組合せて用い得る。また培地には、ナトリウム塩
、カリウム塩、マグネシウム塩、リン酸塩、その他の重
金属塩等も必要に応じて適宜添加使用され得る。The medium used for culture may be any medium containing a nutrient source that can be used by the S-632 substance-producing bacteria, and any of various synthetic media, semi-synthetic media, natural media, etc. can be used. As for the medium composition, carbon sources such as glucose, sucrose, fructose, glycerin, dextrin, starch, molasses, corn steep liquor, and organic acids can be used alone or in combination. Nitrogen sources include organic nitrogen sources such as Pharmamedia, peptone, meat extract, yeast extract, soybean flour, casein, amino acids, and urea.
Inorganic nitrogen sources such as sodium nitrate, ammonium sulfate, etc. may be used alone or in combination. In addition, sodium salts, potassium salts, magnesium salts, phosphates, other heavy metal salts, and the like may be added to the medium as appropriate.
尚、培養中発泡の著しい時は、例えば大豆油、亜麻仁油
等の植物油、オクタデカノール、テトラデカノール、ヘ
プタデカノール等の高級アルコール類、各種シリコン化
合物等の消泡剤を適宜培地中に添加することもできる。If there is significant foaming during culture, add antifoaming agents such as vegetable oils such as soybean oil and linseed oil, higher alcohols such as octadecanol, tetradecanol, and heptadecanol, and various silicon compounds to the medium as appropriate. It can also be added.
培地のpHは、やや酸性ないし中性付近とするのが好ま
しい。培養温度は、S−632物質生産菌が良好に生育
する温度、通常的20〜37℃、特に好ましくは約27
〜30℃付近に保つのがよい。培養時間は、液体振盪培
養及び通気撹拌培養のいずれの場合も、一般に3〜8日
間程度とされる。上記培養によって目的とするS−63
2−B、およびS−632B2物質が生成蓄積される。The pH of the medium is preferably slightly acidic to near neutral. The culture temperature is a temperature at which S-632 substance-producing bacteria grow well, usually 20 to 37°C, particularly preferably about 27°C.
It is best to keep the temperature around ~30°C. The culture time is generally about 3 to 8 days in both cases of liquid shaking culture and aerated agitation culture. The target S-63 obtained by the above culture
2-B and S-632B2 substances are produced and accumulated.
勿論上述した各種の培養条件は、使用微生物の種類や特
性、外部条件等に応じて適宜変更でき、またそれぞれに
応じて上記範囲から最適条件を選択、調節できる。Of course, the various culture conditions described above can be changed as appropriate depending on the type and characteristics of the microorganism used, external conditions, etc., and optimal conditions can be selected and adjusted from the above ranges according to each.
この培養により生産された抗生物質等として有用なS−
632B+およびS−632−82物質を単離するには
発酵生産物を採取する一般的な方法に準じて行なうこと
ができる。例えば溶媒抽出、液体交換、あるいは結晶化
等の各種手段を単独または任意の順序に組合せて用いる
ことができる。S- produced by this culture is useful as an antibiotic, etc.
The 632B+ and S-632-82 substances can be isolated according to a general method for collecting fermentation products. Various means such as solvent extraction, liquid exchange, or crystallization can be used alone or in combination in any order.
より詳しくは、上記培養により生産されるS−632−
B、およびS−632−82物質は主として培養液体(
炉液)中に存在するので、常法に従いまずp過、遠心分
離等を行なって、培養炉液と菌体固形分とを分離し、得
られたS−632−81およびS−632−B2物質を
含む培養炉液については、水と混合しない酢酸エチル、
クロロホルム、ブタノール等の溶媒を用いてS−632
−B、およびS−632−82物質を有機溶媒層に転溶
させ、得られた溶媒層に芒硝を加え、脱水後、溶媒を減
圧下で留去すればS−632B+およびS−632−8
2物質を含む粗抽出物を得ることができる。必要があれ
ば、塩酸又は硫酸にてpHを調節したり、又工業用食塩
等を加えることにより抽出効率を高くしたり、エマルジ
ョン防止などの方法を講じることができる。More specifically, S-632- produced by the above culture
B, and S-632-82 substances are mainly cultured liquid (
Since S-632-81 and S-632-B2 are present in the culture furnace liquid), first perform p-filtration, centrifugation, etc. according to the usual method to separate the culture furnace liquid from the bacterial solids. For fermentation fluids containing substances, ethyl acetate, immiscible with water,
S-632 using a solvent such as chloroform or butanol
-B and S-632-82 substances are transferred to an organic solvent layer, Glauber's salt is added to the obtained solvent layer, and after dehydration, the solvent is distilled off under reduced pressure to produce S-632B+ and S-632-82.
A crude extract containing two substances can be obtained. If necessary, methods such as adjusting the pH with hydrochloric acid or sulfuric acid, increasing the extraction efficiency by adding industrial salt, etc., and preventing emulsion can be taken.
更に精製するためには通常の脂溶性低分子物質の精製手
段を適用できる。すなわちシリカゲル、アルミナ、マク
ロポーラス非イオン系吸着樹脂等の吸着剤による種々の
吸着クロマトグラフィー、および0DS−結合型シリカ
ゲル等を用いる逆相クロマトグラフィーが使用できる。For further purification, conventional means for purifying fat-soluble low molecular weight substances can be applied. That is, various types of adsorption chromatography using adsorbents such as silica gel, alumina, and macroporous nonionic adsorption resins, and reverse phase chromatography using ODS-bonded silica gel and the like can be used.
これらのうち、溶出溶媒にクロロホルム/アセトン、酢
酸エチル/ベンゼン等の混合溶媒系を用いるシリカゲル
クロマトグラフィーおよびアセトニトリル/水、メタノ
ール/水等の混合溶媒系を溶出に用いる逆相クロマトグ
ラフィーが最も有効に利用できる。Of these, silica gel chromatography uses a mixed solvent system such as chloroform/acetone or ethyl acetate/benzene as an elution solvent, and reversed phase chromatography uses a mixed solvent system such as acetonitrile/water or methanol/water for elution. Available.
また、更に精製を必要とする場合には上記クロマトグラ
フィーをくり返し行なうか又は溶出溶媒にメタノールを
用いたセファデックスLH−20(ファルマシア社製)
によるゲル濾過クロマトグラフィーなどを適宜組みあわ
せて行なうことにより、高純度のS−632B+および
S−632−82物質を単離、精製することができる。If further purification is required, the above chromatography may be repeated or Sephadex LH-20 (manufactured by Pharmacia) using methanol as the elution solvent.
Highly pure S-632B+ and S-632-82 substances can be isolated and purified by performing gel filtration chromatography in appropriate combinations.
実施例 次に実施例を挙げて更に詳細に説明する。Example Next, a more detailed explanation will be given with reference to examples.
なお、精製工程中の有効物質の確認は、S−632B+
およびS−63282物質により増殖抑制作用のみられ
る微生物、例えばサツカロマイセス セレビシェ IF
o 0304(S accharomyces e
erevisiae I F O0304)を用いる
バイオアッセイ法と、薄層クロマトグラフィーまたはペ
ーパークロマトグラフィーで展開させた後、上記検定菌
によるバイオオートグラフィーで検出する方法やヨード
蒸気で発色して検出する方法を併用するのが良い。In addition, confirmation of active substances during the purification process is performed using S-632B+.
and microorganisms whose growth is inhibited by the S-63282 substance, such as Satucharomyces cerevisiae IF.
o 0304 (Saccharomyces e
erevisiae I F O0304) and a method in which the test bacteria are developed using thin layer chromatography or paper chromatography and then detected by bioautography using the above-mentioned test bacteria or a method in which color development is performed using iodine vapor is used in combination. It's good.
又、ヒト鼻咽腔癌山来の株化培養細胞(KB細胞)に対
する殺細胞効果を調べることにより、有効画分を確認す
ることができる。Furthermore, the effective fraction can be confirmed by examining the cell killing effect on cultured human nasopharyngeal cancer cell lines (KB cells).
実施例1s−632B+およびS−632−B2物質の
製造
グルコース0.1%、グリセロール4.0%、ポテトス
ターチ0.2%、大豆粉2.0%、ペプトン0.5%、
乾燥酵母0.5%、塩化ナトリウム0.5%、炭酸カル
シウム0.2%よりなる培地(pH7,0)100mQ
を500 mGの三角フラスコに分注し、滅菌後、スト
レプトミセス・スピーシーズS−632株(微工研条寄
第1849号)を−白金耳量接種し、27°Cで72時
間回転振盪培養した(毎分220回転、振幅7cm)。Example 1 Production of s-632B+ and S-632-B2 substances Glucose 0.1%, glycerol 4.0%, potato starch 0.2%, soy flour 2.0%, peptone 0.5%,
Medium (pH 7.0) consisting of 0.5% dry yeast, 0.5% sodium chloride, and 0.2% calcium carbonate 100mQ
was dispensed into a 500 mG Erlenmeyer flask, and after sterilization, a platinum loopful of Streptomyces sp. strain S-632 (Feikoken Jokyo No. 1849) was inoculated and cultured with rotational shaking at 27°C for 72 hours. (220 revolutions per minute, amplitude 7 cm).
次に、グリセロール3.0%、グルコース0.2%、ポ
テトスターチ0.2%、ペプトン0.3%、乾燥酵13
J0.5%、塩化ナトリウム0.3%よりなる培地(p
H6,4)を500 mQの三角フラスコに100mQ
ずつ分注し、滅菌後、上記の種菌を5%の割合で加え、
27℃、144時間回転振盪培養した。培養終了後、培
養液(12,6Ω、pH8,2〜8.4)を採取し、遠
心、濾過後、希水酸化ナトリウム溶液でpH7,6に調
整し、酢酸エチル(2ρ)で3回撹拌抽出した。この酢
酸エチル抽出画分を水で洗浄し、無水硫酸ナトリウムで
乾燥後、減圧濃縮して黄褐色の油状物質(6g)を得た
。この油状物質をクロロホルム/アセトン(約20mQ
)に溶解し、シリカゲルカラムクロマトグラフィー(メ
ルク社製「キーゼルゲル」、6、OX45cm)に吸着
させ、クロロホルム/アセトン(4:1)で溶出した。Next, glycerol 3.0%, glucose 0.2%, potato starch 0.2%, peptone 0.3%, dry fermentation 13
A medium (p
H6,4) in a 500 mQ Erlenmeyer flask at 100 mQ.
After sterilization, add the above inoculum at a rate of 5%,
Rotary shaking culture was carried out at 27°C for 144 hours. After culturing, collect the culture solution (12.6Ω, pH 8.2-8.4), centrifuge, filter, adjust the pH to 7.6 with dilute sodium hydroxide solution, and stir 3 times with ethyl acetate (2ρ). Extracted. This ethyl acetate extracted fraction was washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a yellowish brown oil (6 g). This oily substance was mixed with chloroform/acetone (approximately 20 mQ
), adsorbed on silica gel column chromatography (Merck Kieselgel, 6, OX 45 cm), and eluted with chloroform/acetone (4:1).
溶出フラクションのサツカロマイセス・セレビシェ I
Fo 0304を用いるバイオアッセイにより、S−
632−B、およびS−632−82物質の両方を含む
活性画分を集め、溶媒を留去及乾固して、淡黄色油状物
質(429■)を得た。Elution fraction of Satucharomyces cerevisiae I
By bioassay using Fo 0304, S-
The active fractions containing both 632-B and S-632-82 substances were collected, and the solvent was distilled off and dried to give a pale yellow oil (429).
得られた油状物質をアセトニトリル/水(20:80)
約6mQ)に溶解し、不溶物を遠心分離にて除去した後
、その1/3容をODS結合型シリカゲルカラム(山善
社製rMM1515J 、1.5X50cm)に吸着さ
せ、アセトニトリル/水(20: 80)で溶出した。The resulting oil was dissolved in acetonitrile/water (20:80).
After removing insoluble matter by centrifugation, 1/3 of the volume was adsorbed on an ODS-bonded silica gel column (Yamazen Co., Ltd. rMM1515J, 1.5 x 50 cm), and acetonitrile/water (20:80 ) was eluted.
溶出フラクションのバイオアッセイにより、S−632
B+およびS−632B2物質を含む活性画分をそれぞ
れ集め、有機溶媒を減圧留去した後、水溶液を凍結乾燥
して、淡黄色油状物質、19mg(S−632−B+
) 、6mg (8632B2 )をそれぞれ得た。By bioassay of elution fractions, S-632
The active fractions containing B+ and S-632B2 substances were collected, the organic solvent was distilled off under reduced pressure, and the aqueous solution was freeze-dried to obtain a pale yellow oily substance, 19 mg (S-632-B+
) and 6 mg (8632B2) were obtained, respectively.
得られた3 632 B+およびS−632−B2
物質の系列寒天平板希釈法によるサブロー(S abo
uraud)寒天培地での真菌類に対する最小発育阻止
濃度(MIC)は第2表の通りである。The obtained 3 632 B+ and S-632-B2
Substance series Sabo by agar plate dilution method
The minimum inhibitory concentration (MIC) against fungi on agar medium (uraud) is shown in Table 2.
S−632B+およびS−63282物質は、サツカロ
マイセス(S aceharomyccs)属の酵母類
に活性を示した。Substances S-632B+ and S-63282 showed activity against yeasts of the genus Saceharomyccs.
また、S−632B+およびS−632−B2物質のヒ
ト鼻咽腔癌山来の株化培養細胞(KB細胞)に対する5
0%増殖抑制濃度(ICso)はそれぞれ0.03およ
び3μg / mQであった。In addition, the S-632B+ and S-632-B2 substances have a
The 0% growth inhibitory concentration (ICso) was 0.03 and 3 μg/mQ, respectively.
第1図はS−632B+物質の紫外吸収スペクトルを、
第2図はS−632−82物質の紫外吸収スペクトルを
夫々示す。第3図はS−632−B、物質の赤外吸収ス
ペクトルを、第4図はS−63282物質の赤外吸収ス
ペクトルを夫々示す。第5図はS−632B+物質の核
磁気共鳴スペクトルを、第6図はS−632−82物質
の核磁気共鳴スペクトルを夫々示す。
(以 上)Figure 1 shows the ultraviolet absorption spectrum of S-632B+ substance.
FIG. 2 shows the ultraviolet absorption spectra of the S-632-82 substance. FIG. 3 shows the infrared absorption spectrum of the S-632-B material, and FIG. 4 shows the infrared absorption spectrum of the S-63282 material. FIG. 5 shows the nuclear magnetic resonance spectrum of the S-632B+ material, and FIG. 6 shows the nuclear magnetic resonance spectrum of the S-632-82 material. (that's all)
Claims (1)
ル法による)。 (3)元素分析値(%):C62.76、 H7.71、N4.12。 (4)比旋光度:〔α〕^2^5_D=+68°(C=
1.0)クロロホルム中)。 (5)紫外吸収スペクトル:エタノール中、λmax(
nm)(ε):206(14500)、282(450
)。チャートを第1図に示す。 (6)赤外吸収スペクトル:液膜法(クロロホルム中)
、νmax(cm^−^1):3490、2915、1
710、1697、1370、1245。チャートを第
3図に示す。 (7)核磁気共鳴スペクトル:重クロロホルム中、10
0MHzで測定したチャートを第5図に示す。 (8)溶解性:メタノール、エタノール、クロロホルム
、アセトン、酢酸エチル、ジメチルスルホキシドに良く
溶け、ヘキサン、エーテルにわずかに溶け、水に不溶で
ある。 (9)呈色反応:ヨード蒸気、硫酸、エーリッヒ、リン
モリブデン酸反応に陽性。ニンヒドリン、トレンス反応
に陰性。 (10)塩基性、酸性、中性の区別:弱酸性。 [2]次の性質を有するS−632−B_2物質。 (1)性状:淡黄色油状物質。 (2)分子量:323(電子衝撃(EI)マススペクト
ル法による)。 (3)元素分析値(%):C62.59、 H7.91、N4.23。 (4)比旋光度:〔α〕^2^5_D=+73°(C=
1.0、クロロホルム中)。 (5)紫外吸収スペクトル:エタノール中、λmax(
nm)(ε):207(14800)、280(610
)。チャートを第2図に示す。 (6)赤外吸収スペクトル:液膜法(クロロホルム中)
、νmax(cm^−^1):3350、2920、1
725、1705、1250。 チャートを第4図に示す。 (7)核磁気共鳴スペクトル:重クロロホルム中、10
0MHzで測定したチャートを第6図に示す。 (8)溶解性:メタノール、エタノール、クロロホルム
、アセトン、酢酸エチル、ジメチルスルホキシドに良く
溶け、ヘキサン、エーテルにわずかに溶け、水に不溶で
ある。 (9)呈色反応:ヨード蒸気、硫酸、エーリッヒ、リン
モリブデン酸反応に陽性。ニンヒドリン、トレンス反応
に陰性。 (10)塩基性、酸性、中性の区別:弱酸性。[Claims] [1] S-632-B_1 substance having the following properties. (1) Properties: Pale yellow oily substance. (2) Molecular weight: 323 (according to electron impact (EI) mass spectroscopy). (3) Elemental analysis values (%): C62.76, H7.71, N4.12. (4) Specific optical rotation: [α]^2^5_D=+68°(C=
1.0) in chloroform). (5) Ultraviolet absorption spectrum: in ethanol, λmax(
nm) (ε): 206 (14500), 282 (450
). The chart is shown in Figure 1. (6) Infrared absorption spectrum: liquid film method (in chloroform)
, νmax (cm^-^1): 3490, 2915, 1
710, 1697, 1370, 1245. The chart is shown in Figure 3. (7) Nuclear magnetic resonance spectrum: in deuterated chloroform, 10
A chart measured at 0 MHz is shown in FIG. (8) Solubility: Well soluble in methanol, ethanol, chloroform, acetone, ethyl acetate, and dimethyl sulfoxide, slightly soluble in hexane and ether, and insoluble in water. (9) Color reaction: Positive for iodine vapor, sulfuric acid, Ehrlich, and phosphomolybdic acid reactions. Negative for ninhydrin and Tollens reaction. (10) Distinction between basic, acidic, and neutral: Weakly acidic. [2] S-632-B_2 substance having the following properties. (1) Properties: Pale yellow oily substance. (2) Molecular weight: 323 (according to electron impact (EI) mass spectroscopy). (3) Elemental analysis values (%): C62.59, H7.91, N4.23. (4) Specific rotation: [α]^2^5_D=+73°(C=
1.0 in chloroform). (5) Ultraviolet absorption spectrum: in ethanol, λmax(
nm) (ε): 207 (14800), 280 (610
). The chart is shown in Figure 2. (6) Infrared absorption spectrum: liquid film method (in chloroform)
, νmax (cm^-^1): 3350, 2920, 1
725, 1705, 1250. The chart is shown in Figure 4. (7) Nuclear magnetic resonance spectrum: in deuterated chloroform, 10
A chart measured at 0 MHz is shown in FIG. (8) Solubility: Well soluble in methanol, ethanol, chloroform, acetone, ethyl acetate, and dimethyl sulfoxide, slightly soluble in hexane and ether, and insoluble in water. (9) Color reaction: Positive for iodine vapor, sulfuric acid, Ehrlich, and phosphomolybdic acid reactions. Negative for ninhydrin and Tollens reaction. (10) Distinction between basic, acidic, and neutral: Weakly acidic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63118873A JP2576883B2 (en) | 1988-05-16 | 1988-05-16 | S-632-bottom 1 and S-632-bottom 2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63118873A JP2576883B2 (en) | 1988-05-16 | 1988-05-16 | S-632-bottom 1 and S-632-bottom 2 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01289491A true JPH01289491A (en) | 1989-11-21 |
JP2576883B2 JP2576883B2 (en) | 1997-01-29 |
Family
ID=14747232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63118873A Expired - Lifetime JP2576883B2 (en) | 1988-05-16 | 1988-05-16 | S-632-bottom 1 and S-632-bottom 2 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2576883B2 (en) |
-
1988
- 1988-05-16 JP JP63118873A patent/JP2576883B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2576883B2 (en) | 1997-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4764602A (en) | Antibiotics, and their production | |
JPH01289491A (en) | S-632-b1 and s-632-b2 substance | |
JPH0912550A (en) | 2,2'-bipyridine derivative, its production and antineoplastic agent containing the same | |
JPH0578322A (en) | New antibiotic sf2738 substance, its production and carcinostatic agent | |
JPH06166684A (en) | S-632-c substance | |
WO2005111055A1 (en) | Novel antibiotic kigamicins and use thereof | |
JPS632266B2 (en) | ||
JPS6015318B2 (en) | New antibiotic SF-1942 substance, its manufacturing method and anticancer agent containing it | |
JPH0625277A (en) | Bacterium producing novel testosterone-5alpha-reductase-inhibiting substance, sna-4606, novel testosterone-5-reductase-inhibiting substance, sna-4606 and its production | |
JP4113923B2 (en) | Novel alkaloids urubactin D, E, and methods for producing them | |
JPS63170392A (en) | Scm-127 substance and preparation thereof | |
JP2594085B2 (en) | SF2575, a new antitumor antibiotic, and method for producing the same | |
JPS6348284A (en) | Novel antibiotic yp-02908l-a and production thereof | |
JPS6323996B2 (en) | ||
JPH0360836B2 (en) | ||
JPS61224993A (en) | Antibiotic b-2289an and production thereof | |
JP2001055386A (en) | Antibiotic tubelactomicin b, d and e, and production thereof | |
JPS59156295A (en) | Antibiotic y-0834h-a substance and its preparation | |
JPH0425950B2 (en) | ||
JPS6135788A (en) | Physiologically active substance ss20846a and its preparation | |
JPH0565297A (en) | Enopeptin a, its production and antiviral agent | |
JPH06256324A (en) | New antibiotic ko-7888b, c, d and production thereof | |
JPS6167492A (en) | Novel antibiotic substance ss21020a and its preparation | |
JPH10310584A (en) | Antifungal compound | |
JPS59162892A (en) | Novel antibiotic substance rk-1339 and its preparation |